Ordinary promoter vaccines are the future fighting with COVID-19 infection, top genome experts says Kumar Jeetendra | March 15, 2021 Standard booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain’s attempt to sequence the virus’s genomes told Reuters. The novel coronavirus, which has killed 2.65 million individuals globally since it emerged in China in late 2019, …
FDA approves first AI based COVID-19 non-diagnostic screening Kumar Jeetendra | March 21, 2021 Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic testing apparatus that identifies certain biomarkers that are indicative of some kinds of conditions, such as hypercoagulation (a condition causing blood to clot more readily than normal). The Tiger Tech COVID Plus …
Scientists use genetics to recognize likely drugs for early administration of COVID-19 Kumar Jeetendra | April 12, 2021 A new study using human genetics indicates researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine at March 2021. The purpose is to identify present drugs, either FDA-approved or in clinical development for other conditions, that can …
Small SARS-CoV-2 protein may have huge ramifications for future COVID-19 medicines Kumar Jeetendra | April 12, 2021 A very small protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future therapies, according to a team of Penn State researchers. Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with …
Pregnancy builds the danger of first-time symptomatic kidney stone Kumar Jeetendra | April 15, 2021 Though researchers have long known that several physiological and anatomical changes occur during pregnancy which could contribute to kidney stone formation, evidence of the connection has been lacking. An observational study that reviewed the medical records for nearly 3,000 female patients from 1984 to 2012 finds that pregnancy increases the risk of a first-time symptomatic …
Three-sided molded spikes help the success of Covid transmission Kumar Jeetendra | April 16, 2021 COVID-19 requires no introduction. This past year, the disease, which is caused by the virus SARS-CoV-2, reached every continent across the globe. From the end of March 2021, there had been an estimated 128 million cases listed with nearly three million of these being deadly. As scientists’ race to produce vaccines and politicians coordinate their …
FDA denies EUA for monoclonal antibody treatment bamlanivimab to treat patients with COVID Kumar Jeetendra | April 18, 2021 Now, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody treatment bamlanivimab, when administered alone, to be utilized for treating mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants …
EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail used in the treatment of Covid-19 Kumar Jeetendra | May 5, 2021 Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients Partners with Cipla for pan-India distribution At a global level, Roche and its partner Regeneron are collaborating to …
Sri Lanka endorses Pfizer COVID-19 vaccine for emergency use Kumar Jeetendra | May 8, 2021 Sri Lanka on Saturday approved Pfizer’s COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India. Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 …
What is the Moderna COVID immunization? Does it work, and is it safe? Kumar Jeetendra | May 16, 2021 Overnight, Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. The deal includes ten million doses against the original strain of the coronavirus to be delivered this year. This vaccine has been widely used in countries such as Canada, United States and the United Kingdom …
Too soon to say second wave has topped; immunization accessibility national bottleneck: CRISIL Kumar Jeetendra | May 17, 2021 Even as new COVID-19 infections have shown a declining trend, credit rating agency Crisil on Monday said it is “too early” to say that the second wave of the pandemic has peaked and flagged concerns over the vaccination drive. After opening up the vaccination for all adults, the drive has suffered because availability of vaccines …
